Thursday, May 13, 2004
The long-term cost of drug price controls
["EU Brain Drain on Drugs," Quote To Note, HealthFactsandFears.com, 5 May 2004.]
From The Financial Times:
Research shows that while European consumers are getting drug prices up to a third below U.S. levels, their nations are paying a cost by losing research and development jobs to countries where better profits are being made. Price controls and slow approval processes are viewed by drug companies as hurting Europe's ability to compete with the U.S., and in the long term, the study shows, Europe will pay an economic price for lower drug prices.
["EU Brain Drain on Drugs," Quote To Note, HealthFactsandFears.com, 5 May 2004.]
From The Financial Times:
Research shows that while European consumers are getting drug prices up to a third below U.S. levels, their nations are paying a cost by losing research and development jobs to countries where better profits are being made. Price controls and slow approval processes are viewed by drug companies as hurting Europe's ability to compete with the U.S., and in the long term, the study shows, Europe will pay an economic price for lower drug prices.
Comments:
Post a Comment
